IGLV3-21
Immunoglobulin lambda variable 3-21
Also known as: LV321_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P80748
- Gene
- IGLV3-21
- Ensembl
- ENSG00000211662
- Chromosome
- 22
- Canonical length
- 117 aa
- Protein class
- Immunoglobulin genes, Predicted secreted proteins
- Secretome location
- Immunoglobulin genes
OverviewNCBI Gene
Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle and extracellular exosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
117 residues, UniProt reviewed canonical sequence.
>P80748|IGLV3-21
1 MAWTVLLLGL LSHCTGSVTS YVLTQPPSVS VAPGQTARIT CGGNNIGSKS VHWYQQKPGQ
61 APVLVVYDDS DRPSGIPERF SGSNSGNTAT LTISRVEAGD EADYYCQVWD SSSDHPTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGLV3-21 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 1,697 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 1,697 nTPM
- urinary bladder: 726 nTPM
- stomach: 474 nTPM
- spleen: 398 nTPM
- colon: 335 nTPM
- duodenum: 330 nTPM
Single-cell type
- plasma cells: 84 nCPM
- gastric chief cells: 9.8 nCPM
- parietal cells: 7.1 nCPM
- late spermatids: 5.8 nCPM
- late primary spermatocytes: 3.8 nCPM
- early spermatids: 3.5 nCPM
Immune cell
- memory B-cell: 433 nTPM
- naive B-cell: 226 nTPM
- total PBMC: 37 nTPM
- neutrophil: 0.9 nTPM
- myeloid DC: 0.3 nTPM
- basophil: 0.2 nTPM
Brain region
- choroid plexus: 2.9 nTPM
- cerebral cortex: 2.7 nTPM
- white matter: 2.3 nTPM
- medulla oblongata: 1.6 nTPM
- pons: 0.6 nTPM
- amygdala: 0.5 nTPM
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGLV3-21 as an antibody target. Whether an autoantibody or antibody against IGLV3-21 could matter depends on whether native IGLV3-21 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGLV3-21 is annotated at the cell surface, where native IGLV3-21 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IGLV3-21 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...